Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Advanced Drug Delivery Systems
Papers in
-
- Advanced Drug Delivery Systems 9
- Biomaterials 23
- Nanoparticle-Based Drug Delivery 23
- Top scholars
- Valérie NicolasGabriel PerlemuterSylvie NaveauAnne-Marie. Auteur du texte CassardPatrice CodognoCosmin Sebastian VoicanChantal BauvyAudrey Solgadi
- Journals
- International Journal of Pharmaceutics (18 papers)PLoS ONE (8 papers)Journal of Controlled Release (6 papers)Journal of Hepatology (5 papers)European Journal of Medicinal Chemistry (5 papers)
- Partner nations
- FranceCanadaUnited States
In The Last Decade
Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
252 papers receiving 9.9k citations
Peers
Comparison fields: 5 of 143
- Biomaterials 738
- Pharmaceutical Science 384
- Pulmonary and Respiratory Medicine 1.6k
- Epidemiology 1.4k
- Molecular Biology 2.2k
Countries citing scholars working at Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
This map shows the geographic impact of research produced by authors working at Ingénierie et Plateformes au Service de l'Innovation Thérapeutique. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ingénierie et Plateformes au Service de l'Innovation Thérapeutique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingénierie et Plateformes au Service de l'Innovation Thérapeutique more than expected).
Fields of papers published by authors at Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
This network shows the impact of papers affiliated with Ingénierie et Plateformes au Service de l'Innovation Thérapeutique at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ingénierie et Plateformes au Service de l'Innovation Thérapeutique at the time of their publication.
About Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
In recent decades, authors affiliated with Ingénierie et Plateformes au Service de l'Innovation Thérapeutique have published 260 papers, which have received a total of 10k indexed citations . Scholars at this organization have produced 18 papers in Pharmaceutical Science, 23 papers in Biomaterials, 5 papers in Endocrinology, 7 papers in Biochemistry and 67 papers in Molecular Biology on the topics of Nanoparticle-Based Drug Delivery (23 papers), Pulmonary Hypertension Research and Treatments (14 papers), Phosphodiesterase function and regulation (11 papers), Advanced Drug Delivery Systems (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Gut microbiota and health (8 papers), Lipid metabolism and biosynthesis (7 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). Their work is cited by papers focused on Biomaterials (738 citations), Pharmaceutical Science (384 citations), Pulmonary and Respiratory Medicine (1.6k citations), Epidemiology (1.4k citations) and Molecular Biology (2.2k citations). Authors at Ingénierie et Plateformes au Service de l'Innovation Thérapeutique collaborate with scholars in France, Canada and United States and have published in prestigious journals including International Journal of Pharmaceutics, PLoS ONE, Journal of Controlled Release, Journal of Hepatology and European Journal of Medicinal Chemistry. Some of Ingénierie et Plateformes au Service de l'Innovation Thérapeutique's most productive authors include Valérie Nicolas, Gabriel Perlemuter, Sylvie Naveau, Anne-Marie. Auteur du texte Cassard, Patrice Codogno, Cosmin Sebastian Voican, Chantal Bauvy, Audrey Solgadi, Patrick Couvreur and Pierre Chaminade.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.